scholarly journals Impact of beta‐blocker use on the long‐term outcomes of heart failure patients with chronic obstructive pulmonary disease

2021 ◽  
Author(s):  
Yoshiaki Kubota ◽  
Wan Ting Tay ◽  
Tiew‐Hwa Katherine Teng ◽  
Kuniya Asai ◽  
Takashi Noda ◽  
...  
Keyword(s):  
Heart Failure ◽  
Chronic Obstructive Pulmonary Disease ◽  
Pulmonary Disease ◽  
Beta Blocker ◽  
Chronic Obstructive ◽  
Long Term Outcomes ◽  
Obstructive Pulmonary Disease ◽  
Heart Failure Patients

scholarly journals Characteristics of Beta-blocker Treatment in Cardiac Patients with Concomitant Chronic Obstructive Pulmonary Disease

2016 ◽  
Vol 1 (3) ◽  
pp. 276-279
Author(s):  
Attila Frigy ◽  
Katalin Mezei ◽  
Ildikó Kocsis ◽  
Lehel Máthé
Keyword(s):  
Heart Failure ◽  
Chronic Obstructive Pulmonary Disease ◽  
Dilated Cardiomyopathy ◽  
Pulmonary Disease ◽  
Beta Blocker ◽  
Scientific Data ◽  
Cardiac Patients ◽  
Chronic Obstructive ◽  
Obstructive Pulmonary Disease ◽  
Heart Failure Patients

Abstract Background: Recent scientific data demonstrated a potential beneficial effect of beta-blocker (BB) therapy in cardiac patients with chronic obstructive pulmonary disease (COPD). Our aim was to characterize the use of beta-blockers in these patients, in “real-life” conditions. Material and methods: We collected retrospectively the data of 60 consecutive cardiac patients (51 men, 9 women, mean age 67 years) with the concomitant diagnosis of COPD: main cardiac conditions, presence and reason of BB therapy, type of drug and dosage, main ECG and echocardiographic parameters, medication and data regarding COPD. Besides descriptive statistics, we compared the data of patients with and without BB therapy (chi-square test, level of significance alpha <0.05) in order to identify factors associated with BB usage. Results: In our study population, 41.6% of the patients had received BB treatment, the most frequently used drug being bisoprolol 2.5 mg and 5 mg q.d. (28%-28%), followed by carvedilol (32%). The prevalence of BB therapy was 51.2% in heart failure patients (48% in NYHA class III and IV, and 66.6% in dilated cardiomyopathy), 38.4% in hypertension, 81.8% in ischemic artery disease, and 64.7% in subjects with atrial fibrillation. The usage of BB therapy was significantly associated with the presence of heart failure (p = 0.047), dilated cardiomyopathy (p = 0.034), ischemic heart disease (p = 0.005), previous myocardial infarction (p = 0.003) and, inversely, with the acute exacerbation of COPD (p = 0.006). Conclusions: Despite the fact that every cardiac patient with COPD had a potential indication for BB treatment, this was used insufficiently, especially in case of heart failure patients. In daily practice, there is a need for continuous review and improvement of BB usage in these patients.

Open-label, randomized comparison trial of long-term outcomes of levofloxacin versus standard antibiotic therapy in acute exacerbations of chronic obstructive pulmonary disease

Respirology ◽  
2007 ◽  
Vol 12 (1) ◽  
pp. 117-121 ◽  
Author(s):  
Agustin RUIZ-GONZÁLEZ ◽  
Antonio GIMÉNEZ ◽  
Xavier GÓMEZ-ARBONÉS ◽  
Jorge SOLER-GONZÁLEZ ◽  
Virginia SÁNCHEZ ◽  
...  
Keyword(s):  
Chronic Obstructive Pulmonary Disease ◽  
Antibiotic Therapy ◽  
Pulmonary Disease ◽  
Chronic Obstructive ◽  
Long Term Outcomes ◽  
Open Label ◽  
Obstructive Pulmonary Disease ◽  
Acute Exacerbations ◽  
Comparison Trial

scholarly journals Beta-blocker choice and exchangeability in patients with heart failure and chronic obstructive pulmonary disease: an Italian register-based cohort study

2019 ◽  
Vol 9 (1) ◽  
Author(s):  
Maurizio Sessa ◽  
Annamaria Mascolo ◽  
Daniel Bech Rasmussen ◽  
Kristian Kragholm ◽  
Magnus Thorsten Jensen ◽  
...  
Keyword(s):  
Heart Failure ◽  
Chronic Obstructive Pulmonary Disease ◽  
Cohort Study ◽  
Pulmonary Disease ◽  
Beta Blocker ◽  
Chronic Obstructive ◽  
Obstructive Pulmonary Disease ◽  
Patients With Heart Failure

Long-Term Outcomes in Mild/Moderate Chronic Obstructive Pulmonary Disease in the European Community Respiratory Health Survey

2009 ◽  
Vol 180 (10) ◽  
pp. 956-963 ◽  
Author(s):  
Roberto de Marco ◽  
Simone Accordini ◽  
Josep M. Antò ◽  
Thorarinn Gislason ◽  
Joachim Heinrich ◽  
...  
Keyword(s):  
Chronic Obstructive Pulmonary Disease ◽  
Pulmonary Disease ◽  
European Community ◽  
Health Survey ◽  
Respiratory Health ◽  
Chronic Obstructive ◽  
Long Term Outcomes ◽  
Obstructive Pulmonary Disease
Sign in / Sign up

Export Citation Format

Share Document